Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

How many patients are eligible for disease-modifying treatment in Alzheimer's disease? A French national observational study over 5 years.

Epelbaum S, Paquet C, Hugon J, Dumurgier J, Wallon D, Hannequin D, Jonveaux T, Besozzi A, Pouponneau S, Hommet C, Blanc F, Berly L, Julian A, Paccalin M, Pasquier F, Bellet J, Boutoleau-Bretonniere C, Charriau T, Rouaud O, Madec O, Mouton A, David R, Bekadar S, Fabre R, Liegey E, Deberdt W, Robert P, Dubois B.

BMJ Open. 2019 Jun 24;9(6):e029663. doi: 10.1136/bmjopen-2019-029663.

2.

Randomised, placebo-controlled, double-blind, double-dummy, multicentre trial comparing electronic cigarettes with nicotine to varenicline and to electronic cigarettes without nicotine: the ECSMOKE trial protocol.

Berlin I, Dautzenberg B, Lehmann B, Palmyre J, Liégey E, De Rycke Y, Tubach F.

BMJ Open. 2019 May 24;9(5):e028832. doi: 10.1136/bmjopen-2018-028832.

Supplemental Content

Loading ...
Support Center